Indaptus Therapeutics, Inc.
INDP
$0.4649
-$0.0151-3.15%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.60% | 1.21% | -7.71% | 1.54% | -7.68% |
| Total Depreciation and Amortization | -41.67% | -16.67% | 0.00% | 6.67% | -29.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -9.03% | 18.17% | 28.57% | 3.74% | -10.21% |
| Change in Net Operating Assets | 175.72% | 333.37% | 104.40% | 95.01% | 67.22% |
| Cash from Operations | 8.07% | 11.41% | 8.14% | 17.04% | -2.50% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -43.19% | 230.57% | 203.26% |
| Cash from Investing | -- | -100.00% | -43.19% | 230.57% | 204.34% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -302.81% | -192.84% | -245.83% | 111.12% | 112.66% |